与射频剥离结合的左心房尾关闭:对患有心脏动症的患者左心房功能的影响
Jing Lv1,2, Rui Wang1, Jing Yang1
1Division of Cardiology, The Second Hospital of Hebei Medical University, Xinhua District, Shijiazhuang, Hebei, 050051, China.
Open medicine (Warsaw, Poland)
|April 16, 2024
概括
左心房附属物关闭 (LAAC) 结合导管切除 (CA) 在患有心房动 (AF) 的患者中显示左心房功能暂时下降. 这些功能在12个月内完全恢复.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电子生理学 电子生理学
背景情况:
- 阴性心房动 (AF) 构成中风的风险.
- 导管切除 (CA) 是一种常见的AF治疗方法.
- 左心房尾关闭 (LAAC) 是一种替代性中风预防策略.
研究的目的:
- 评估联合CA和Watchman LAAC对左心房 (LA) 结构和功能的影响.
- 为了比较患者接受单独CA的LA功能与与LAAC配合的CA.
主要方法:
- 具有倾向性得分匹配的前性队列研究.
- 在联合CA + LAAC组的89名患者和在单独CA组的89名患者中.
- 在12个月内使用心声学评估LA结构,储备,腹筋和功能.
主要成果:
- 这两组在手术后的LA功能中都出现了初步改善.
- LA功能逐渐恢复,在3个月后恢复到手术前的水平.
- 组合治疗组在前3个月内经历了LA储备和功能显著但暂时下降.
结论:
- 与CA结合的LAAC可能会对LA储备和功能产生短期的部分负面影响.
- 这些影响是暂时的,在程序后12个月内完全消失.
- CA和LAAC的组合不会导致LA功能的长期有害变化.
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


